Daurismo
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Daurismo, covering 2017-08-01 to 2025-05-07. Get the full timeline:
Most recent: EMA Authorised: Daurismo (Glasdegib maleate) — Pfizer Europe MA EEIG